Role of PET/CT in Peritoneal Deposits Assessment

Launched by AYA KHALED MAHMOUD · Nov 14, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at how a special imaging test called PET/CT can help doctors assess peritoneal deposits in patients with peritoneal metastases, which are cancerous growths in the abdominal cavity. The trial will involve patients who have a known primary cancer, those with cancer that has spread but whose original source is unknown, and individuals who have incidental findings of peritoneal lesions during other examinations.

To participate in this trial, patients should be between the ages of 65 and 74 and must have certain types of cancer as mentioned. However, if a patient cannot remain still during the imaging, is very ill, cannot lie still for about 20 minutes, or is pregnant, they won't be eligible to join. For those who qualify, they can expect to undergo a PET/CT scan, which is a non-invasive test that allows doctors to see inside the body and gather more information about their condition. This trial is not yet recruiting participants, but it aims to provide valuable insights into better assessing and understanding peritoneal deposits in cancer patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • • Suspected patients known to have a primary malignant tumour, patients with metastasis of unknown primary and had incidental peritoneal lesions.
• Exclusion Criteria:
• • • Patients unable to sit calm without movement during imaging.
• • Severely ill patients.
• • Patients unable to sleep in a fixed position for 20 minutes.
• • Pregnancy